OneSource powers second generic semaglutide nod in Canada

Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs

World Asthma Day: Apollo Spectra Hospital urges early diagnosis and treatment adherence

Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India

Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases

Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access

Silent cough, deadly risk: Doctors warn of hidden asthma surge amid rising pollution

Marking World Asthma Day 2026, doctors sounded the alarm over a steady surge in respiratory illnesses

Microbot Medical expands LIBERTY Robotic System commercial rollout

The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts

SetPoint Medical launches first-in-human MS pilot study using implanted nerve stimulation device

Eton Pharmaceuticals relaunches HEMANGEOL with new distribution model

The company says the product will now be distributed exclusively through Anovo Specialty Pharmacy

Gufic Biosciences deepens global oncology push with fresh investment in Australia’s Selvax

Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology

FDA advisory panel backs AstraZeneca prostate cancer combo in decisive vote

The Committee backed the combination based on results from the CAPItello-281 Phase III trial, marking a key milestone in the regulatory pathway for AstraZeneca’s targeted therapy strategy in prostate cancer

India unveils first-ever national framework to tackle childhood diabetes

New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system